Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Microbix receives milestone payment under ThromboClear agreement with Gensia

July 25, 1997

Novel fibrinogen/integrin receptor antagonists described by Merck KGaA

July 22, 1997

DuPont Merck prepares anticoagulant aminoboronic acids

July 21, 1997

Fibrinogen-antagonistic oxopiperazine derivatives from Yamanouchi

July 17, 1997

Potent, orally active fibrinogen antagonist developed at Merck & Co.

July 17, 1997

Texas Biotechnology initiates NDA filing for Novastan

July 16, 1997

Merck & Co. develops potent and selective pyridinone acetamide thrombin inhibitor

July 16, 1997

Lp(a)-dependent actions of LMWH

July 14, 1997

Antithrombotic efficacy of TAK-029 in animal models

July 11, 1997

Roberts seeks European approval of Agrylin

July 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...